The study titled “Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year” evaluated the efficacy of intra-articular injections of micro-fragmented adipose tissue (MFAT) alone versus a combination of MFAT and platelet-rich plasma (PRP) in patients with hip osteoarthritis (OA).
Methodology:
- Participants: A total of 147 patients with grade 1-4 hip OA were included in the study.
- Interventions: Patients received either MFAT injections or a combination of MFAT and PRP.
- Outcome Measures: The primary outcomes assessed were the Visual Analogue Scale (VAS) for pain and the Oxford Hip Score (OHS) over a one-year period.
Findings:
- Pain Reduction: Both treatment groups experienced significant improvements in VAS scores, with over 60% of patients reporting a reduction of 20 points or more.
- Functional Improvement: OHS scores improved similarly in both groups, indicating enhanced hip function.
- Comparative Efficacy: No significant differences were observed between the MFAT-only and MFAT + PRP groups in terms of pain relief or functional outcomes.
Conclusion:
The study suggests that intra-articular injections of MFAT, with or without PRP, are effective in reducing pain and improving function in patients with hip OA. The addition of PRP did not confer additional benefits over MFAT alone. This finding is particularly relevant for patients with a low body mass index (BMI), where obtaining sufficient adipose tissue for MFAT treatment may be challenging; the combination with PRP could be a viable alternative.
These results support the potential role of biological therapies in managing hip osteoarthritis, offering a less invasive option compared to surgical interventions.Link to the article: Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year
